Target intelligence / Profile preview

Suppression of tumorigenicity 13 pseudogene (ST13P)

Target
ST13P
Molecular classification
Pseudogene
01

Overview

Suppression of tumorigenicity 13 pseudogene (Ensembl: ENSG00000258230) is a non-protein-coding segment of human DNA that closely resembles the functional ST13 gene but does not encode a protein product[4][6][16]. The parent gene, ST13, encodes a co-chaperone protein (Hsc70-interacting protein, HIP) that modulates heat shock protein activity and has been proposed, though not conclusively proven, as a tumor suppressor[1][7]. However, the pseudogene variant referenced here does not contribute directly to cellular biological functions or disease processes and is not a therapeutic target. There is no documented role for this specific pseudogene as a biomarker, drug target, or in disease pathology, and it is primarily of interest as a genomic annotation[4][6][16]. Note: If you are interested in the functional protein-coding gene *Suppression of tumorigenicity 13* (ST13/HIP), this is a different entity with potential—though as yet only limited—association with tumor suppression[1][7][13]. The pseudogene does not share those properties.

Other names
Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogeneST13PGC12M102166GC12M101774GC12M101809GC12M101899GC12M102002GC12M102110GC12M102253GC12M102378GC12M102488GC12M102600GC12M102716GC12M102842GC12M102968GC12M103078

Beyond the preview

Go deeper on Suppression of tumorigenicity 13 pseudogene (ST13P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Suppression of tumorigenicity 13 pseudogene (ST13P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call